Richard Malamut

This profile gathers the share dealings of Richard Malamut across 2 companies, led by Collegium Pharmaceutical, Inc and Pelthos Therapeutics Inc. We count 20 filings; the first trade dates from 1 April 2019 and the latest from 2 April 2026.

On the open market, the record shows 1 purchase worth €8,869 and 2 sales worth €11k. Netting one side against the other leaves €1,823 of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 17 share grants. Since January 2026: no purchases and 2 sales on the market.

Most recently, on 6 April 2026, the filings show an open-market sale worth €5,509 in Pelthos Therapeutics Inc. The last insider purchase was made public on 16 September 2024, 768 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.